FDA Approves Adagrasib for KRAS G12C–Mutated CRC
The US Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics, Inc.) with cetuximab for ...
Read moreThe US Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics, Inc.) with cetuximab for ...
Read more© 2023 earth-news.info